[SGMO] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
24-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -2,519.61%
YoY- -991.42%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 2,042 27,230 27,986 25,800 54,851 26,837 13,077 -26.60%
PBT -60,568 -51,714 -37,563 -40,567 4,501 -19,219 -13,091 29.07%
Tax -272 259 -67 108 179 -1,246 -468 -8.64%
NP -60,296 -51,973 -37,496 -40,604 4,555 -18,664 -13,091 28.97%
Tax Rate - - - - -3.98% - - -
Total Cost 62,338 79,203 65,482 66,404 50,296 45,501 26,168 15.55%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -2,952.79 -190.87 -133.98 -157.38 8.30 -69.55 -100.11 75.73%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.34 -0.32 -0.26 -0.29 0.04 -0.18 -0.15 14.60%
EPS Diluted -0.34 -0.32 -0.26 -0.29 0.04 -0.18 -0.15 14.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.